152 related articles for article (PubMed ID: 23053792)
1. Gender- and ethnicity-specific survival trends of oral cavity and oropharyngeal cancers in British Columbia.
Auluck A; Hislop G; Bajdik C; Hay J; Bottorff JL; Zhang L; Rosin MP
Cancer Causes Control; 2012 Dec; 23(12):1899-909. PubMed ID: 23053792
[TBL] [Abstract][Full Text] [Related]
2. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience.
Auluck A; Hislop G; Bajdik C; Poh C; Zhang L; Rosin M
Cancer; 2010 Jun; 116(11):2635-44. PubMed ID: 20336792
[TBL] [Abstract][Full Text] [Related]
3. Population-based incidence trends of oropharyngeal and oral cavity cancers by sex among the poorest and underprivileged populations.
Auluck A; Walker BB; Hislop G; Lear SA; Schuurman N; Rosin M
BMC Cancer; 2014 May; 14():316. PubMed ID: 24886308
[TBL] [Abstract][Full Text] [Related]
4. Sociodemographic differences in the incidence of oropharyngeal and oral cavity squamous cell cancers in New Zealand.
Chelimo C; Elwood JM
Aust N Z J Public Health; 2015 Apr; 39(2):162-7. PubMed ID: 25827186
[TBL] [Abstract][Full Text] [Related]
5. Abstracting stage in population-based cancer registries: the example of oral cavity and oropharynx cancers.
de Camargo Cancela M; Chapuis F; Curado MP
Cancer Epidemiol; 2010 Aug; 34(4):501-6. PubMed ID: 20452853
[TBL] [Abstract][Full Text] [Related]
6. Socio-economic deprivation: a significant determinant affecting stage of oral cancer diagnosis and survival.
Auluck A; Walker BB; Hislop G; Lear SA; Schuurman N; Rosin M
BMC Cancer; 2016 Aug; 16():569. PubMed ID: 27480165
[TBL] [Abstract][Full Text] [Related]
7. Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia.
Elwood JM; Youlden DR; Chelimo C; Ioannides SJ; Baade PD
Cancer Epidemiol; 2014 Feb; 38(1):16-21. PubMed ID: 24445141
[TBL] [Abstract][Full Text] [Related]
8. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
[TBL] [Abstract][Full Text] [Related]
9. Rising population of survivors of oral squamous cell cancer in the United States.
Patel MA; Blackford AL; Rettig EM; Richmon JD; Eisele DW; Fakhry C
Cancer; 2016 May; 122(9):1380-7. PubMed ID: 26950886
[TBL] [Abstract][Full Text] [Related]
10. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Patient Distribution of Oral Cavity and Oropharyngeal SCC in Canada.
Ghazawi FM; Lu J; Savin E; Zubarev A; Chauvin P; Sasseville D; Zeitouni A; Litvinov IV
J Cutan Med Surg; 2020; 24(4):340-349. PubMed ID: 32238063
[TBL] [Abstract][Full Text] [Related]
12. Demographic and Clinicopathologic Distribution of Oral Cavity and Oropharyngeal Cancer in Alberta, Canada: A Comparative Analysis.
Ganatra S; Sawani S; Badri P; Pakseresht M; Amin M
J Can Dent Assoc; 2022 Dec; 88():m10. PubMed ID: 37098276
[TBL] [Abstract][Full Text] [Related]
13. Trends in the incidence of oral cavity and oropharyngeal cancers in Spain.
de Souza DL; de Camargo Cancela M; Pérez MM; Curado MP
Head Neck; 2012 May; 34(5):649-54. PubMed ID: 21717523
[TBL] [Abstract][Full Text] [Related]
14. Oral and oropharyngeal cancer in a Venezuelan population.
Rivera H; Nikitakis NG; Correnti M; Maissi S; Ponce JG
Acta Odontol Latinoam; 2008; 21(2):175-80. PubMed ID: 19177856
[TBL] [Abstract][Full Text] [Related]
15. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control.
de Souza DL; Pérez MM; Curado MP
Cancer Epidemiol; 2011 Dec; 35(6):510-4. PubMed ID: 21470934
[TBL] [Abstract][Full Text] [Related]
16. Oral Cavity and Oropharyngeal Cancer Surveillance and Control in Alberta: A Scoping Review.
Badri P; Ganatra S; Baracos V; Lai H; Amin MS
J Can Dent Assoc; 2021 Jan; 87():l4. PubMed ID: 34343067
[TBL] [Abstract][Full Text] [Related]
17. Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands.
van Dijk BA; Brands MT; Geurts SM; Merkx MA; Roodenburg JL
Int J Cancer; 2016 Aug; 139(3):574-83. PubMed ID: 27038013
[TBL] [Abstract][Full Text] [Related]
18. Trends in mortality rates for oral and oropharyngeal cancer in Spain, 1979-2018.
Duran-Romero AJ; Infante-Cossio P; Pereyra-Rodriguez JJ
Oral Dis; 2022 Mar; 28(2):336-344. PubMed ID: 33305413
[TBL] [Abstract][Full Text] [Related]
19. The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.
LeHew CW; Weatherspoon DJ; Peterson CE; Goben A; Reitmajer K; Sroussi H; Kaste LM
Epidemiol Rev; 2017 Jan; 39(1):132-147. PubMed ID: 28402398
[TBL] [Abstract][Full Text] [Related]
20. Declining oral cancer rates in Sri Lanka: are we winning the war after being at the top of the cancer league table?
Ariyawardana A; Warnakulasuriya S
Oral Dis; 2011 Oct; 17(7):636-41. PubMed ID: 21762396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
